{
     "PMID": "19159642",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20090427",
     "LR": "20131121",
     "IS": "0091-3057 (Print) 0091-3057 (Linking)",
     "VI": "92",
     "IP": "2",
     "DP": "2009 Apr",
     "TI": "Hesperidin, a flavonoid glycoside with sedative effect, decreases brain pERK1/2 levels in mice.",
     "PG": "291-6",
     "LID": "10.1016/j.pbb.2008.12.016 [doi]",
     "AB": "The aim of this work was to evaluate if the intraperitoneal administration of the natural compound hesperidin, in a sedative dose, and neo-hesperidin, a hesperidin structural analog that exerts minor sedative effect, were able to induce changes in intracellular signaling cascades in different areas of the brain. The systemic administration of hesperidin produced a marked reduction in the phosphorylation state of extracellular signal-regulated kinases 1/2 (ERK 1/2), but not of Ca(+2)/calmodulin-dependent protein kinase II alpha subunit (alphaCaMKII), in the cerebral cortex, cerebellum and hippocampus. In contrast, neo-hesperidin did not markedly affect the activity of ERK 1/2 in both the cortex and the cerebellum. Taken together, these results demonstrated that intracellular signalling involving a selective decrease in ERK1/2 activation accompanied the depressant action of hesperidin. Even more, the low sedative action of neo-hesperidin correlates with a negligible decrease in phosphorylation state of ERK 1/2 (pERK 1/2), suggesting that low levels of pERK 1/2 in CNS could be a marker of sedative efficacy of flavonoids.",
     "FAU": [
          "Martinez, M Cecilia",
          "Fernandez, Sebastian P",
          "Loscalzo, Leonardo M",
          "Wasowski, Cristina",
          "Paladini, Alejandro C",
          "Marder, Mariel",
          "Medina, Jorge H",
          "Viola, Haydee"
     ],
     "AU": [
          "Martinez MC",
          "Fernandez SP",
          "Loscalzo LM",
          "Wasowski C",
          "Paladini AC",
          "Marder M",
          "Medina JH",
          "Viola H"
     ],
     "AD": "Instituto de Biologia Celular y Neurociencias, Facultad de Medicina, Universidad de Buenos Aires, Paraguay 2155, 3 degrees Piso, C1121ABG, Argentina.",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article",
          "Research Support, Non-U.S. Gov't"
     ],
     "DEP": "20081231",
     "PL": "United States",
     "TA": "Pharmacol Biochem Behav",
     "JT": "Pharmacology, biochemistry, and behavior",
     "JID": "0367050",
     "RN": [
          "0 (Hypnotics and Sedatives)",
          "E750O06Y6O (Hesperidin)",
          "EC 2.7.11.24 (Mitogen-Activated Protein Kinase 1)",
          "EC 2.7.11.24 (Mitogen-Activated Protein Kinase 3)"
     ],
     "SB": "IM",
     "MH": [
          "Animals",
          "Behavior, Animal/*drug effects",
          "Brain/*drug effects/enzymology",
          "Hesperidin/*pharmacology",
          "Hypnotics and Sedatives/*pharmacology",
          "Male",
          "Mice",
          "Mitogen-Activated Protein Kinase 1/*metabolism",
          "Mitogen-Activated Protein Kinase 3/*metabolism",
          "Phosphorylation",
          "Signal Transduction"
     ],
     "EDAT": "2009/01/23 09:00",
     "MHDA": "2009/04/28 09:00",
     "CRDT": [
          "2009/01/23 09:00"
     ],
     "PHST": [
          "2008/09/10 00:00 [received]",
          "2008/12/10 00:00 [revised]",
          "2008/12/18 00:00 [accepted]",
          "2009/01/23 09:00 [entrez]",
          "2009/01/23 09:00 [pubmed]",
          "2009/04/28 09:00 [medline]"
     ],
     "AID": [
          "S0091-3057(08)00412-7 [pii]",
          "10.1016/j.pbb.2008.12.016 [doi]"
     ],
     "PST": "ppublish",
     "SO": "Pharmacol Biochem Behav. 2009 Apr;92(2):291-6. doi: 10.1016/j.pbb.2008.12.016. Epub 2008 Dec 31.",
     "term": "hippocampus"
}